- Abstract Number: 3124 • 2016 ACR/ARHP Annual Meeting - Huntingtin Interacting Protein 1 (Hip1) Is a New Arthritis Severity GeneBackground/Purpose: Cia25/Pia42 is an arthritis severity and joint damage quantitative trait locus on rat chromosome 12 previously identified in an intercross between MHC identical but…
- Abstract Number: 3125 • 2016 ACR/ARHP Annual Meeting - Secular Trend of Premature Mortality in Gout: A Contrast from Rheumatoid ArthritisBackground/Purpose: Gout and rheumatoid arthritis (RA), the two most common inflammatory arthritides, are both associated with premature mortality. General population-based studies have found substantially reduced…
- Abstract Number: 3126 • 2016 ACR/ARHP Annual Meeting - Computational Polarizing Microscopy: A Novel Method to Detect Birefringent Crystals Using Lens-Free on-Chip MicroscopyBackground/Purpose: A compensated polarizing microscopy has been used for detecting monosodium urate (MSU) or calcium pyrophosphate dihydrate (CPPD) crystals to confirm the diagnosis of gout…
- Abstract Number: 3127 • 2016 ACR/ARHP Annual Meeting - Ultrasound Evaluation of the Achilles Tendon in Tophaceous Gout: A Case-Control StudyUltrasound Evaluation of the Achilles Tendon in Tophaceous Gout: A Case-Control Study Background/Purpose: Tendon involvement in the lower limbs in gout is frequent. Tophus deposition…
- Abstract Number: 3128 • 2016 ACR/ARHP Annual Meeting - A Longitudinal Dual Energy Computed Tomography Study on the Effect of Urate Lowering Therapies on the Reduction of Tophus Burden in Patients with Chronic GoutBackground/Purpose: Dual energy computed tomography (DECT) allows reliably detecting and quantifying tophus burden in patients with chronic gout. Longitudinal studies on the effect of uric…
- Abstract Number: 3129 • 2016 ACR/ARHP Annual Meeting - The Pharmacokinetics of Oxypurinol in Patients Treated with Hemodialysis and AllopurinolBackground/Purpose: Allopurinol is recommended as a first-line pharmacologic urate-lowering therapy in gout. Oxypurinol, the active metabolite of allopurinol, is entirely cleared by the kidneys. Oxypurinol…
- Abstract Number: 3130 • 2016 ACR/ARHP Annual Meeting - Development and Pilot Testing of an Online Educational Tool for Gout Patients — Mygoutcare®Background/Purpose: Recent management guidelines for gout have identified several unmet educational needs in gout patients. Qualitative studies have documented the paucity of patient-focused materials which…
- Abstract Number: 3131 • 2016 ACR/ARHP Annual Meeting - Pregabalin Is More Effective in Treating Hand Osteoarthritis Pain Than Duloxetine or Placebo: A Double-Blind Randomized Controlled TrialBackground/Purpose: A prospective, randomized, double-blind, placebo-controlled trial from 42 primary care and rheumatology clinics in the UK. We recruited 85 participants: 65 with hand OA…
- Abstract Number: 3132 • 2016 ACR/ARHP Annual Meeting - Protective Effects of Replacing Sedentary Time with Light and Moderate to Vigorous Physical Activity on Functional Limitation in Knee OABackground/Purpose: Physical activity protects the development of functional limitation in knee osteoarthritis (OA). But little is known about the protective effects of physical activity intensity,…
- Abstract Number: 3133 • 2016 ACR/ARHP Annual Meeting - Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal Intensity Alteration and Knee Structural and Symptomatic Abnormalities in Patients with Symptomatic Knee OsteoarthritisBackground/Purpose: Infrapatellar fat pad (IPFP), a local adipose tissue, may have important contributions to knee osteoarthritis (OA). IPFP signal intensity alterations on MRI may represent…
- Abstract Number: 3134 • 2016 ACR/ARHP Annual Meeting - Hydroxychloroquine Is Not Effective in Reducing Symptoms of Hand Osteoarthritis: Results from a Placebo-Controlled Randomised TrialBackground/Purpose: Synovitis is prevalent in OA and associated with pain. Hydroxychloroquine (HCQ) is used routinely for treating synovitis in inflammatory arthritis. The primary aim of…
- Abstract Number: 3135 • 2016 ACR/ARHP Annual Meeting - Influence of Baseline Magnetic Resonance Imaging Features on Outcomes of Operative and Non-Operative Treatment of Meniscal Tear in Patients ≥ 45Background/Purpose: In the treatment of meniscal damage in the setting of mild to moderate osteoarthritis (OA), several randomized trials found that both arthroscopic partial meniscectomy…
- Abstract Number: 3136 • 2016 ACR/ARHP Annual Meeting - Impact of Novel Smartphone Application on Pain and Mobility in Osteoarthritis Patients Treated with Hylan G-F 20Background/Purpose: Methods: In this study, both groups were treated with hylan G-F 20 and showed significantly increased mobility and reduced pain, however, patients using the…
- Abstract Number: 3137 • 2016 ACR/ARHP Annual Meeting - Assessing System-Level Performance Measures for Early Rheumatoid Arthritis in a Large Multicenter Cross-Country Prospective 8-Year Observational Cohort StudyBackground/Purpose: The Arthritis Alliance developed a set of 6 performance measures to evaluate timely access to care and treatment for inflammatory arthritis. A national study…
- Abstract Number: 3138 • 2016 ACR/ARHP Annual Meeting - Sustained Improvement in Follow-up of Hypertension in Rheumatology Patients: Results of an Intervention Sustainability AssessmentBackground/Purpose: Hypertension (HTN) is the most prevalent comorbid cardiovascular disease (CVD) risk factor among adults with rheumatic conditions. However, we previously found that high blood…
